Invasive Home Ventilation in Denmark

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorRigshospitalet, Denmark

About this trial

The aim of this study is to describe national trends over the past 10 years in patients receiving invasive home mechanical ventilation (HMV) in Denmark. This includes indications for invasive HMV, diagnostic groups, and one-year mortality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients are included if they have or have had a respiratory certified personale care assistent during the period 2016-2025.

Disqualifiers

Not tracheostomized

Tracheostomized but on spontaneous breathing throughout 1 January 2016 - 31 December 2025

Not discharged to home, assisted living, nursing home, or rehabilitation during 1 January 2016 - 31 December 2025

Trial population

Patients in Denmark with a respiratory certified personale care assistent who are fully or partially dependent on invasive ventilation during the period 2016-2025.

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

450 Participants
are grouped into 1 trial group
Group A: Invasive mechanical ventilation

Trial outcomes

Primary outcomes

1

Incidence of patients with invasive home mechanical ventilation

Incidence of patients with invasive home mechanical ventilation per year per 100,000 population

Time frame
Each year during the periode from 01.01.2016 to 12.31.2025

Secondary outcomes

1

Prevalence of patients on home mechanical ventilation pr. year

Time frame
Each year during the periode from 01.01.2016 to 12.31.2025
2

Number of new patients on invasive home mechanical ventilation per year

The absolute number of patients starting on invasive home mechanical ventilation each year.

Time frame
Each year during the periode from 01.01.2016 to 12.31.2025
3

One-year mortality

1-year mortality after initiation of invasive home mechanical ventilation

Time frame
Periode from 01.01.2016 to 12.31.2025

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rigshospitalet, Denmark

Lead sponsor

Aarhus University Hospital

Collaborator

Odense University Hospital

Collaborator